Tuesday, July 29, 2014

Top 5 Healthcare Technology Companies To Invest In Right Now

Next Tuesday, LDK Solar (NYSE: LDK  ) will release its latest quarterly results. Lately, investors have had to wonder whether the Chinese solar company will be able to continue operating, as LDK is one of many solar companies in the emerging-market nation going through a cash crunch due to large losses.

LDK Solar isn't the only Chinese solar company having to deal with a dearth of cash and extensive debt, but its negative margins have produced huge losses that are clearly unsustainable in the long run. If LDK can emerge as a survivor in the coming shakeout in the industry, then it might have a chance to reach profitability if the resulting contraction in supply pushes prices higher. Let's take an early look at what's been happening with LDK Solar over the past quarter and what we're likely to see in its quarterly report.

Stats on LDK Solar

Analyst EPS Estimate

10 Best Healthcare Technology Stocks To Buy Right Now: SEI Investments Co (SEIC)

SEI Investments Company (SEI), incorporated on November 18, 1968, is a global provider of investment processing, investment management, and investment operations solutions. The Company helps corporations, financial institutions, financial advisors, and ultra-high-net-worth families create and manage wealth by providing comprehensive, investment and investment-business solutions. The Company�� business segments include Private Banks , Investment Advisors , Institutional Investors, Investment Managers and Investments in New Businesses.

The Company�� wealth management business solutions include investment processing outsourcing solutions for banks, trust companies, independent wealth advisers, and investment managers; investment management programs for affluent individual investors and for institutional investors, including retirement plan sponsors, and not-for-profit organizations; and investment operations outsourcing solutions for investment management firms, banks and investment companies that sponsor and distribute mutual funds, hedge funds, and alternative investments.

The Company�� Investment processing solutions consist of application and business process outsourcing services, professional services, and transaction-based services. It delivers these solutions to providers of institutional and private client wealth management services, including banks, trust companies, independent wealth advisers, and other financial services firms. It also delivers these solutions, combined with its investment management programs, to investment advisory firms and other financial services firms that provide wealth management services to their advisory clients. The Company�� investment processing solutions are enabled through two platforms, TRUST 3000 and the Global Wealth Platform (GWP).

Investment management programs consists of money market, fixed-income and equity mutual funds and other collective investment products, alternative investment portfolios, and separate! ly managed accounts. The Company serves as the sponsor, administrator and investment advisor for many of these products. It distributes these programs primarily through investment advisory firms, including investment advisors and banks, and directly to institutional or individual investors. Investment operations outsourcing solutions consist of accounting and administration services, and distribution support services. It delivers these solutions to investment management firms that offer traditional and alternative products.

Private Banks

The Private Banks segment delivers a comprehensive outsourcing solution integrating investment processing services, investment management and distribution programs, and business to banks and trust institutions worldwide, independent wealth advisers and other wealth managers located in the United Kingdom, and financial advisors in Canada. The Company owns, maintains and operates the software applications and information processing facilities for all of its investment processing solutions.

Private banks and other trust organizations who utilizes its TRUST 3000 application solution outsource investment processing technology software and computer processing, but retain responsibility for investment operations, client administration, and investment management. These clients operate its TRUST 3000 application remotely while fully supported by its data center using dedicated telecommunications networks.

Investment Advisors

The Investment Advisors segment offers wealth management solutions to registered investment advisors, many of whom are affiliated with or are registered as independent broker-dealers, financial planners, and life insurance agents located throughout the United States. These wealth management solutions include the Company�� investment management programs and back-office investment processing outsourcing services and are usually offered on a bundled basis. Its solutions helps investment ! advisors ! reduce risk, improve quality, and gain operational efficiency to devote more of their resources to servicing their clients and acquiring new clients. Advisors are responsible for the investor relationship which includes creating financial plans, implementing investment strategies and educating and servicing their customers. Advisors may customize portfolios to include separate account managers provided through its programs as well as SEI-sponsored mutual funds.

Institutional Investors

The Institutional Investors segment offers investment management programs and administrative outsourcing solutions for retirement plan sponsors, hospitals, and not-for-profit organizations globally. Clients can outsource their investment management needs and the administration for defined benefit plans, defined contribution plans, endowments, foundations, and other balance sheet assets. The fiduciary management outsourcing program provides a strategic platform integrating the Manager-of-Managers investment process, plan administration services, and consulting services. Plan administration services include trustee, custodial, benefit payment services, record-keeping services, and donor administration. Consulting services include actuarial services, asset liability modeling, and the customization of an asset allocation.

Investment Managers

The Investment Managers segment provides a platform of comprehensive investment operations outsourcing solutions to investment managers globally. This array of front-, middle- and back-office investment processing services integrates industry tools and technology to support a manager's diverse business needs across multiple product types and structures, investment strategies and asset classes. The Company provides outsourcing services including fund and investment accounting, administration, reconciliation, investor servicing and client reporting. It also provides comprehensive solutions to managers focused on alternative investments who ! manage he! dge funds, funds of hedge funds, private equity funds, real estate and infrastructure funds, across registered, partnership and separate account structures domiciled in the United States and overseas.

Investments in New Businesses

The Investments in New Businesses segment represents other business ventures or research and development activities intended to expand its solutions to new or existing markets including ultra-high-net-worth families who reside in the United States. This segment includes the costs associated with business development in the Middle East through its Dubai office and the development of a Internet-based investment management application. The family wealth management solution offers flexible family-office type services through a personalized solution while utilizing the Manager-of-Managers investment process.

The Company competes with Fidelity National Information Services, Inc., SunGard Data Systems Inc., State Street Corporation, Fi-Tek LLC, Charles Schwab & Co., Inc.,Fidelity Investments,Pershing LLC, FNZ UK Ltd., Temenos Group AG, Avaloq, TD Direct Investing (Europe) Ltd.,Russell Investment Group,Franklin Templeton Investments,AssetMark Investment Services Inc., Brinker Capital, EnvestNet Asset Management, Inc., Lockwood Advisors, Inc., Charles Schwab & Co., Inc., Northern Trust Corporation, State Street and BNY Mellon.

Advisors' Opinion:
  • [By Marc Bastow]

    Investment and fund processing and management company SEI Investments (SEIC) raised its semi-annual dividend 10% 22 cents per share, payable on Jan. 10 to shareholders of record as of Dec. 23.
    SEIC Dividend Yield: 1.33%

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on SEI Investments (Nasdaq: SEIC  ) , whose recent revenue and earnings are plotted below.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on SEI Investments (Nasdaq: SEIC  ) , whose recent revenue and earnings are plotted below.

Top 5 Healthcare Technology Companies To Invest In Right Now: Rambus Inc.(RMBS)

Rambus Inc. engages in the creation, design, development, and licensing of patented innovations, technologies, and architectures to digital electronics products and systems. Its patented innovations include Dual Edge Clocking, which is designed to allow data to be sent on the clock pulse; Variable Burst Length that improves data transfer efficiency by allowing varying amounts of data to be sent per a memory read or write request in dynamic random access memory (DRAM) and flash memory; and FlexPhase technology, which synchronizes data output and compensates for circuit timing errors. The company also offers Channel Equalization to improve signal integrity and system margins in high speed parallel and serial link channels; Module Threading, which improves the power efficiency of a memory module by applying parallelism to module data accesses; and MicroLens optical design technology, which provides optimum utilization of high-brightness light-emitting diodes (LED) in edge-lit lighting applications. In addition, it licenses its architectures and industry-standard solutions for use in digital electronics products and systems, including XDR Memory Architecture enabling the production of DRAM; XDR2 Memory Architecture that incorporates DRAM micro-threading for graphics intensive applications, such as gaming and digital video; Mobile XDR Memory Architecture, which enables applications, such as HD video recording and 3D gaming on battery powered mobile devices; RDRAM Memory used in play stations, Intel-based personal computers, televisions, and routers; and FlexIO Processor Bus, a high speed chip-to-chip interface. Further, the company offers industry-standard chip interface solutions, including DDRx; digital logic controllers for peripheral component interconnect express and other industry standard interfaces; and custom solutions for displays, LED backlights, and general lighting. Rambus Inc. was founded in 1990 and is headquartered in Sunnyvale, Ca lifornia.

Advisors' Opinion:
  • [By Lauren Pollock]

    Micron Technology Inc.(MU) and Rambus Inc.(RMBS) said they have ended a series of court battles that stretched for 13 years, with Micron agreeing to pay up to $280 million to Rambus over seven years. The deal announced late Monday gives Micron, one of the biggest makers of memory chips, rights to use Rambus patents in certain products. Rambus shares surged 9.7% to $9.36 premarket, while Micron was inactive.

  • [By Rich Bieglmeier]

    One-time Wall Street darling and high-flyer Rambus Inc. (NASDAQ:RMBS) is bucking an ugly, bloody tape. The memory-chip make is up more than 4% as we type thanks to an upgrade from Citi.

  • [By James E. Brumley]

    They say a company is judged by the company it keeps. What's less said - though never disputed - is that a company is equally judged by the kind of talent it can attract... winning people tend to only work for winning companies. In that light, the fact that the newest chief of Endeavor IP Inc. (OTCBB:ENIP) is a former executive from the ranks of Rambus Inc. (NASDAQ:RMBS) and Tessera Technologies, Inc. (NASDAQ:TSRA) should underscore just how seriously the market should be taking ENIP. RMBS and TSRA didn't become large powerhouses by hiring folks who don't know what they're doing, and conversely, the fact that a former Rambus and Tessera Technologies guy was willing to step into the unknown and take the helm at Endeavor IP speaks volumes about the potential of the young company's IP portfolio.

Top 5 Healthcare Technology Companies To Invest In Right Now: EMC Corporation(EMC)

EMC Corporation develops, delivers, and supports the information and virtual infrastructure technologies and solutions. The company offers enterprise storage systems and software, which are deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, as well as provides backup and recovery, and disaster recovery and archiving solutions. It also offers information security solutions in various areas, such as enterprise governance, risk and compliance, data loss prevention, security information management, continuous network monitoring, fraud protection, identity assurance and access control, and encryption and key management. In addition, the company provides information intelligence software, solutions, and services, including EMC Captiva for intelligent enterprise capture; EMC Document Sciences for customer communications management; EMC Kazeon for e-discovery ; EMC Documentum xCP for building business solutions and an action engine for big data; and the EMC Documentum platform for managing and delivering enterprise information. Further, it offers virtual and cloud infrastructure products, such as virtualization and virtualization-based cloud infrastructure solutions that address a range of IT problems, as well as facilitate access to cloud computing capacity, business continuity, software lifecycle management, and corporate end-user computing device management In addition, the company provides consulting, technology deployment, managed, customer support, and training and certification services. EMC Corporation markets its products through direct sales and through multiple distribution channels in North America, Latin America, Europe, the Middle East, South Africa, and the Asia Pacific region. The company was founded in 1979 and is headquartered in Hopkinton, Massachusetts.

Advisors' Opinion:
  • [By Mani]

    EMC Corporation (NYSE: EMC) would publish its third-quarter 2013 financial results on October 22, 2013. The company is also expected to hold a conference call for investors on the same day at�8:30 a.m. ET�on to review the results.

  • [By Dan Caplinger]

    Shares bounced somewhat last month when VMware said it and parent company EMC (NYSE: EMC  ) would spin off VMware's Cloud Foundry service and EMC's data analytics software business. The spinoff, to be called Pivotal, won't go public anytime soon, but it might help focus VMware on making the most of all of its various opportunities.

  • [By MONEYMORNING.COM]

    At the time, I mentioned that a spin-off from computer storage leader EMC Corp. (NYSE: EMC) should do particularly well.

    The spin-off company, Pivotal, marks its one-year anniversary this month as it continues to gain traction in the Internet realm.

Top 5 Healthcare Technology Companies To Invest In Right Now: Tranzyme Inc.(TZYM)

Tranzyme, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of acute and chronic gastrointestinal (GI) motility disorders in the United States and internationally. The company?s clinical product candidates include ulimorelin, an intraveneous ghrelin agonist, which is in the Phase III clinical development stage for the treatment of acute upper GI motility disorders; and TZP-102, an orally-administered ghrelin agonist that has commenced Phase IIb clinical development stage for the treatment of diabetic gastroparesis. Its preclinical product candidates comprise TZP-201, a motilin antagonist for the treatment of various forms of moderate-to-severe diarrhea; and TZP-301, an oral ghrelin antagonist for the treatment of metabolic diseases. The company has strategic collaboration with Bristol-Myers Squibb Company to discover, develop, and commercialize additional novel co mpounds; and a license agreement with Norgine B.V to develop and commercialize ulimorelin in Europe, Australia, New Zealand, the Middle East, and north and South Africa. Tranzyme, Inc. was founded in 1998 and is headquartered in Durham, North Carolina.

Advisors' Opinion:
  • [By CRWE]

    Tranzyme Pharma (Nasdaq:TZYM) reported that it has closed the previously announced underwritten registered direct offering of approximately 3.0 million shares of its common stock at a price of $3.85 per share for gross proceeds, including the over-allotment option, of approximately $11.5 million.

No comments:

Post a Comment